Abeloff, Martin D. (2008). Abeloff's Clinical Oncology.4th ed. Philadelphia: Churchill Livingstone.
Banchereau J and Lebecque S. T. (1996). cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med., 183, 2411-2415.
Coussens LM and Werb Z. (2002). Inflammation and cancer. Nature 420, 860-867.
Choi HJ, Hyun MS, Jung GJ, Kim SS and Hong SH. (1998). Tumor angiogenesis as a prognostic predictor in colorectal carcinoma with special reference to mode of metastasis and recurrence. Oncology, 55, 575-581.
Edmund H. Duthie Jr., Paual R. Katz, Michael L. Malone. (2007). Practice of Geriatrics. 4th ed. Philadelphia: Saunders.
Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C et al. (1994). Matrixdegrading metalloproteinases in tumor progression. Princess Takamatsu Symp., 24, 152-161
Fridman S. (1999). Interleukin-17 a T-cell mediated cytokine promotes tumorigenicity of human cervical tumors in nude mice. Cancer Res., 59, 3698-3704
Garam Kim, Prem Khanal, Sung-Chul Lim, Hyo Jeong Yun, Sang-Gun Ahn, Sung Hwan Ki and Hong Seok Choi. (2012). Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity, Carcinogenesis
Ito H. and Miki C. (1999). Profile of circulating levels of interleukin-1 receptor antagonist and interleukin-6 in colorectal cancer patients. Scand J Gastroenterol 11, 1139-1143.
Jovanovic DV, Di Battista JA, Martel-Pelletier J, Jolicoeur FC, He Y, Zhang M, Mineau F and Pelletier JP. (1998). IL-17 stimulates the production and expression of proinflammatory cytokines, IL-1beta and TNF-alpha by human macrophages. J. Immunol. 160, 3513-3521.
Kato T, Furumoto H, Ogura T, Onishi Y, Irahara M, Yamano S, Kamada M, Aono T (2001). Expression of IL-17 mRNA in ovarian cancer. Conference abstract.
Kato T, Furumoto H, Ogura T, Onishi Y, Irahara M, Yamano S, Kamada M and Aono T. (2001). Expressiom of IL-17 mRNA in Ovarian Cancer. Biochem. Biophys. Res. Commun. 282, 735-738
Komoda H, Tanaka M, Matsuo Y, Hazama K and Takao T. (1998). Interleukin 6 levels in colorectal cancer tissues. World J. Surg. 22, 895-898.
Lust JA and Donovan KA. (1999). The role of interleukin-1‚ in the pathogenesis of multiple myeloma. Hematol Oncol Clin North Am 13, 1117-1125.
Miki C, Tonouchi H, Wakuda R, Hatada T, Inoue Y, Minato E, Kobayashi M and Kusunoki M. (2002). Intra-tumoral interleukin-6 downregulation system and genetic mutations of tumor suppressor genes in colorectal cancer. Cancer 94, 1584-1592.
Numasaki M, Fukushi J, Ono M, Narula SK, Zavodny PJ, Kudo T, Robbins PD, Tahara H, Lotze MT. (2003). Interleukin-17 promotes angiogenesisand tumor growth. Blood 101, 2620-2627.
Pages F, Vives V, Sautes-Fridman C, Fossiez F, Berger A, Cugnenc PH, Tartour E and Fridman WH. (1999). Control of tumor development by intratumoral cytokines. Immunol. Lett. 68, 135-139.
Prause O, Bozinovski S, Anderson GP and Linden A. (2004). Increased matrix metalloproteinase-9 concentration and activity after stimulation with interleukin-17 in mouse airways. Thorax 59, 313-317.
Roeb E, Dietrich CG, Winograd R, Arndt M, Breuer B, Fass J, Scumpelick V and Matern S. (2001). Activity and cellular origin of gelatinases in patients with colon and rectal cancer differential activity of matrix metalloproteinase-2. Cancer 92, 2680-2691.
Shin HC, Benbernou N, Esnault S and Guenounou M. (1999). Expression of IL-17 in human memory CD45RO+ T lymphocytes and its regulation by protein kinase A pathway. Cytokine 11, 257-266.
Tartour E, Fossiez F, Joyeux I, Galinha A, Gey A, Claret E, Sastre- Garau X, Couturier J, Mosseri V, Vives V, Banchereau J, Fridman WH, Wijdenes J, Lebecque S, Sautès-Fridman C. (1999). Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Res. 59, 3698-3704.
Takahashi H, Numasaki M, Lotze MT and Sasaki H. (2005). Interleukin-17 enhances bFGF, HGF and VEGF-induced growth of vascular endothelial cells. Immunol. Lett. 98, 189-193.
Wilson J. and Balkwill F. (2002). The role of cytokines in the epithelial cancer microenvironment. Semin Cancer Biol 12, 113-120.
Wong MP, Cheung N, Yuen ST, Leung SY and Chung LP. (1999). Vascular endothelial growth factor is up-regulated in the early premalignant stage of colorectal tumour progression. Int. J. Cancer 81, 845-850.
Yao Z, Franslow WC, Seldin MF, Rousseau A-M, Painter SL, Comeau MR, Cohen JI and Spriggs MK. (1995). Herpesvirus saimiri encodes a new cytokine IL-17 which binds to novel cytokine receptor. Immunity 3, 811-821.
Zhang QY, Liu S, Ge D, Li C, Xue Y, Zhang QS, and You Z. The role of interleukin-17 in formation and growth of prostate cancer, Tulane University School of Medicine, Cancer research abstract.